COMP <GO>
BTMD vs MRK // OPERATING MARGIN
Biote Corp. (Class A) (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: BTMD 3
— MRK 7
▲ OPERATING MARGIN LEADER: MRK
LAST: $1.11 (-5.13%) • MKT CAP: $42.0M
operating-margins
18.50%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
operating-margins
34.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BTMD VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BTMD | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 20.70% | +64.30 | BTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.9x | 15.3x | -12.40 | BTMD | /valuation <GO> |
| Free Cash Flow Yield | — | 3.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | 18.50% | 34.30% | -15.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | 14.10% | 28.10% | -14.00 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -2.50% | 1.30% | -3.80 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.11% | 2.26% | +1.85 | BTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.50 | 5.19 | -2.69 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.5 | 51.7 | -2.20 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $42.0M | $361.02B | -$360.98B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BTMD REV | MRK REV | BTMD GROSS % | MRK GROSS % | BTMD FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $192.2M | $65.01B | — | 74.8% | $30.2M | $12.36B |
| FY 2024 | $197.2M | $64.17B | — | 76.3% | $38.8M | $18.10B |
| FY 2023 | $185.4M | $60.12B | — | — | $26.9M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BTMD // BETA —
MRK // BETA 0.92